Literature DB >> 17141207

Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels.

Masafumi Koga1, Michio Otsuki, Sueko Matsumoto, Hiroshi Saito, Mikio Mukai, Soji Kasayama.   

Abstract

BACKGROUND: Measurements of glycated albumin (GA) as well as glycated hemoglobin (HbA1c) have been applied in order to monitor chronic glycemic control in diabetic patients. Both glycated proteins are known influenced by various factors other than glycemia. It has recently been reported that GA level is low in obese, non-diabetic children and is negatively associated with body mass index (BMI) in adult diabetic patients. However, the reasons for the connection between obesity and GA remain unknown. The aim of this study was to examine whether BMI and the obesity-related inflammatory marker plasma high-sensitivity C-reactive protein (hs-CRP) are independently associated with GA and HbA1c.
METHODS: Two hundred and twelve non-diabetic subjects (158 with normal glucose tolerance and 54 with impaired glucose tolerance) were enrolled in this study. The effects of fasting plasma glucose (FPG), oral glucose tolerance test (OGTT) 2-h glucose, age, BMI and hs-CRP on HbA1c as well as those on GA were analyzed.
RESULTS: FPG significantly correlated with HbA1c, and also significantly but weakly correlated with GA. BMI showed a significantly positive correlation with HbA1c, whereas it negatively correlated with GA. Plasma hs-CRP showed a weak positive correlation with HbA1c, whereas it was negatively associated with GA. By stepwise multivariate regression analyses, BMI and hs-CRP were negatively associated with GA but not with HbA1c.
CONCLUSIONS: These results demonstrated that BMI as well as hs-CRP were independent negative risks of GA but not of HbA1c in non-diabetic subjects. Obesity and its related chronic inflammation are involved in lower serum GA levels, but not HbA1c levels, in relation to glycemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141207     DOI: 10.1016/j.cca.2006.10.013

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  38 in total

1.  A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study.

Authors:  Anne E Sumner; Michelle T Duong; Paola C Aldana; Madia Ricks; Marshall K Tulloch-Reid; Jay N Lozier; Stephanie T Chung; David B Sacks
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

Review 2.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 3.  Glycated albumin: from biochemistry and laboratory medicine to clinical practice.

Authors:  Elena Dozio; Nicola Di Gaetano; Peter Findeisen; Massimiliano Marco Corsi Romanelli
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

4.  Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.

Authors:  Elizabeth Selvin; Bethany Warren; Xintong He; David B Sacks; Amy K Saenger
Journal:  Clin Chem       Date:  2018-02-07       Impact factor: 8.327

5.  Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in saudi arabia.

Authors:  Ali Ibrahim Al-Sultan
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

6.  Racial differences in neighborhood disadvantage, inflammation and metabolic control in black and white pediatric type 1 diabetes patients.

Authors:  Sara J Coulon; Cruz Velasco-Gonzalez; Richard Scribner; Chi L Park; Ricardo Gomez; Alfonso Vargas; Sarah Stender; Jovanny Zabaleta; Patrice Clesi; Stuart A Chalew; James M Hempe
Journal:  Pediatr Diabetes       Date:  2016-01-18       Impact factor: 4.866

7.  Glycated albumin is associated with body mass index in euglycemic adults but is not predictive of postprandial blood glucose response.

Authors:  Andrew N Reynolds; Ashley Duncan; Devonia Kruimer; Bernard J Venn
Journal:  J Clin Lab Anal       Date:  2016-10-24       Impact factor: 2.352

8.  Age-Adjusted Glycated Albumin at Diagnosis is more Correlated with the Product of Age and Plasma Glucose than Plasma Glucose Alone in Patients with Neonatal Diabetes Mellitus.

Authors:  Akiko Furuya; Shigeru Suzuki; Miho Oshima; Satoshi Amamiya; Atsushi Nakao; Mariko Araki; Kayo Mizutani; Satoshi Hayano; Katsumi Ushijima; Aya Imamoto; Nobuhiko Nagano; Tatsuhiko Urakami; Kumihiro Matsuo; Yusuke Tanahashi; Hiroshi Azuma; Masafumi Koga
Journal:  J Clin Lab Anal       Date:  2016-04-28       Impact factor: 2.352

9.  Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).

Authors:  Steven E Kahn; Steven M Haffner; Giancarlo Viberti; William H Herman; John M Lachin; Barbara G Kravitz; Dahong Yu; Gitanjali Paul; Rury R Holman; Bernard Zinman
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

10.  Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes.

Authors:  Masafumi Koga; Jun Murai; Hiroshi Saito; Soji Kasayama
Journal:  Diabetes Care       Date:  2009-10-21       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.